MicroPort<sup>®</sup> Orthopedics Announces Launch of its EVOLUTION<sup>®</sup> Revision Tibial System and EVOLUTION<sup>®</sup> BioFoam<sup>®</sup> Tibia in US and Europe

Arlington, Tennessee - On April 5, MicroPort Orthopedics Inc., a medical device company that develops and manufactures cutting edge joint replacement implants designed to help patients achieve full function faster, announced the launch of the EVOLUTION® Revision Tibial System and EVOLUTION® BioFoam® Tibia in US and Europe.
 
"MicroPort® Orthopedics continues to grow its product portfolio with a steady cadence of product launches," said Aurelio Sahagun, President, MicroPort® Orthopedics. "These product launches demonstrate our commitment to help improve patient outcomes by giving surgeons a broad array of choices that allow them to treat their patients. We are excited to bring the benefits of the Medial-Pivot design to a revision system."
 
The EVOLUTION® Medial-Pivot Knee System is built on 17 years of clinical success and addresses key issues that can improve satisfaction for patients undergoing total knee replacement. The EVOLUTION® Revision Tibial System is designed to offer surgeons intra-operative flexibility to meet individual anatomic patient needs, address fixation issues caused by poor bone stock, while maintaining the proven kinematic benefits of the Medial-Pivot design. The new system was designed by expert surgeons from Europe, Asia, Canada, and the United States and features all the benefits of the EVOLUTION® Medial-Pivot design.
 
In addition to its EVOLUTION® Revision Tibial System, MicroPort® Orthopedics also announced the launch of its EVOLUTION® BioFoam® Tibia. This launch completes the EVOLUTION® Medial-Pivot Cementless System, which consists of the EVOLUTION® porous femoral component and the new EVOLUTION® BioFoam® tibial component. This system is designed to combine the unrivaled benefits of the Medial-Pivot philosophy with the advantages of early fixation without compromising the long-term demands that are required in today's increasingly young and more active patients. Building on the success of the ADVANCE® BioFoam® Tibia, which reported survivorship of 98% at two years, the EVOLUTION® BioFoam® Tibia will further enhance the product portfolio.
 
"I have used the MicroPort® Orthopedics Medial-Pivot Knee System for three years," said Dr. Brian de Beaubien, M.D., St. John's Providence Park Hospital in Novi, MI. "The majority of my primary knees are cementless, and I do not use screws. In my experience with the ADVANCE® and now EVOLUTION®, BioFoam® has excellent fixation. I have been following x-rays now for several years, and I don't see any radiolucencies or sclerotic lines around the keel, that would suggest movement of the component. The BioFoam® Tibia combined with the unique design of the EVOLUTION® Medial-Pivot Knee is truly different from anything else. It is my go-to knee."